Suppr超能文献

代谢组学:B细胞非霍奇金淋巴瘤诊断或预后的新时代。

Metabolomics: A New Era in the Diagnosis or Prognosis of B-Cell Non-Hodgkin's Lymphoma.

作者信息

Alfaifi Abdullah, Refai Mohammed Y, Alsaadi Mohammed, Bahashwan Salem, Malhan Hafiz, Al-Kahiry Waiel, Dammag Enas, Ageel Ageel, Mahzary Amjed, Albiheyri Raed, Almehdar Hussein, Qadri Ishtiaq

机构信息

Department of Biological Science, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.

Fayfa General Hospital, Ministry of Health, Jazan 83581, Saudi Arabia.

出版信息

Diagnostics (Basel). 2023 Feb 23;13(5):861. doi: 10.3390/diagnostics13050861.

Abstract

A wide range of histological as well as clinical properties are exhibited by B-cell non-Hodgkin's lymphomas. These properties could make the diagnostics process complicated. The diagnosis of lymphomas at an initial stage is essential because early remedial actions taken against destructive subtypes are commonly deliberated as successful and restorative. Therefore, better protective action is needed to improve the condition of those patients who are extensively affected by cancer when diagnosed for the first time. The development of new and efficient methods for early detection of cancer has become crucial nowadays. Biomarkers are urgently needed for diagnosing B-cell non-Hodgkin's lymphoma and assessing the severity of the disease and its prognosis. New possibilities are now open for diagnosing cancer with the help of metabolomics. The study of all the metabolites synthesised in the human body is called "metabolomics." A patient's phenotype is directly linked with metabolomics, which can help in providing some clinically beneficial biomarkers and is applied in the diagnostics of B-cell non-Hodgkin's lymphoma. In cancer research, it can analyse the cancerous metabolome to identify the metabolic biomarkers. This review provides an understanding of B-cell non-Hodgkin's lymphoma metabolism and its applications in medical diagnostics. A description of the workflow based on metabolomics is also provided, along with the benefits and drawbacks of various techniques. The use of predictive metabolic biomarkers for the diagnosis and prognosis of B-cell non-Hodgkin's lymphoma is also explored. Thus, we can say that abnormalities related to metabolic processes can occur in a vast range of B-cell non-Hodgkin's lymphomas. The metabolic biomarkers could only be discovered and identified as innovative therapeutic objects if we explored and researched them. In the near future, the innovations involving metabolomics could prove fruitful for predicting outcomes and bringing out novel remedial approaches.

摘要

B 细胞非霍奇金淋巴瘤具有广泛的组织学和临床特征。这些特征可能使诊断过程变得复杂。淋巴瘤的早期诊断至关重要,因为针对侵袭性亚型采取的早期治疗措施通常被认为是成功且具有恢复性的。因此,需要更好的保护措施来改善那些首次被诊断出患有癌症且受影响广泛的患者的状况。如今,开发新的高效癌症早期检测方法已变得至关重要。迫切需要生物标志物来诊断 B 细胞非霍奇金淋巴瘤、评估疾病的严重程度及其预后。借助代谢组学诊断癌症现在有了新的可能性。对人体合成的所有代谢物的研究称为“代谢组学”。患者的表型与代谢组学直接相关,这有助于提供一些临床有益的生物标志物,并应用于 B 细胞非霍奇金淋巴瘤的诊断。在癌症研究中,它可以分析癌代谢组以识别代谢生物标志物。本综述阐述了 B 细胞非霍奇金淋巴瘤的代谢及其在医学诊断中的应用。还提供了基于代谢组学的工作流程描述,以及各种技术的优缺点。还探讨了预测性代谢生物标志物在 B 细胞非霍奇金淋巴瘤诊断和预后中的应用。因此,可以说与代谢过程相关的异常可能发生在广泛的 B 细胞非霍奇金淋巴瘤中。只有通过探索和研究,代谢生物标志物才能被发现并确定为创新的治疗靶点。在不久的将来,涉及代谢组学的创新可能会在预测结果和提出新的治疗方法方面取得丰硕成果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d768/10000528/a9e7a5bfbadb/diagnostics-13-00861-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验